As We See It – Defying The Reference Ranges
When physicians review a patients blood test results, their only concern is when a particular result is outside the normal laboratory reference range. The problem is that standard reference ranges usually represent average populations, rather than what the optimal range should be to maintain good health.
The lethal consequences of faulty reference ranges have been discussed for many years in Life Extension magazine. As more studies show that a persons health can be severely impaired when physicians rely on standard reference ranges, it becomes imperative for Life Extension members to educate themselves about optimal ranges to avoid becoming a victim of medical ignorance.
It now appears that most standard reference ranges are too broad to adequately detect health problems or prescribe appropriate therapies on an individual basis.
An example of flawed reference ranges can be seen in blood tests used to assess thyroid status. A long-standing controversy has been how to best diagnose thyroid deficiency. Conventional doctors rely on thyroid blood tests, whereas alternative physicians also look for other signs and symptoms of thyroid deficiency. A recent article in The Lancet reveals surprising new findings about reference ranges that may shake up current theories about assessing individual thyroid status.
Before discussing The Lancet article, the reader should be acquainted with the serious consequences of a thyroid hormone deficiency. Aging people encounter a variety of ailments that doctors often attribute to problems other than thyroid deficit. Some of the most noticeable symptoms caused by low thyroid are poor concentration, memory disturbances, cold hands and feet, accumulation of excess body fat, difficulty in losing weight, menstrual problems, dry skin, thin hair and low energy. Some specific disorders related to thyroid deficiency include depression, elevated cholesterol, migraine headaches, hypertension and infertility.[1-9]
Broda O. Barnes, M.D., Ph.D. was a physician-scientist who dedicated more than 50 years of his life to researching, teaching and treating thyroid and related endocrine dysfunctions. In his book entitled, Hypothyroidism: The Unsuspected Illness, Dr. Barnes described over 47 symptoms that may be related to poor thyroid function. During his many years of research and practice, Dr. Barnes condemned conventional doctors who ignored obvious clinical manifestations of thyroid deficiency. According to Dr. Barnes:
In lieu of blood tests, Dr. Barnes advocated that patients measure their temperature upon awakening. If the temperature is consistently below normal ranges, this is indicative of a thyroid deficiency. The box below provides specific instructions on how best to measure your body temperature in order to assess your thyroid hormone status.
Dr. Broda Barnes believed that 40% of the adult population suffers from thyroid deficiency. Based on the percentage of adults now taking prescription drugs to treat depression, elevated cholesterol, high blood pressure and other conditions, Dr. Barnes observations about the epidemic of thyroid deficiency may now be validated.
Whats wrong with thyroid blood tests?
The Lancet is one of the most prestigious scientific journals in the world. It often reports new medical findings that defy conventional wisdom. According to an article published in the August 3, 2002 issue of The Lancet, the problem with thyroid blood tests may be faulty Reference Ranges that fail to reflect what the optimal level of thyroid hormone should be in a particular individual.
As stated earlier in this article, standard laboratory reference ranges represent average populations, rather than what the optimal range should be. Back in the 1960s, for instance, the upper reference range for cholesterol extended to 300 (mg/dL). This number was based on a statistical calculation indicating that it was normal to have total cholesterol levels as high as 300. At that time, it was also normal for men to suffer fatal heart attacks at relatively young ages. As greater knowledge accumulated about the risk of heart attack and high cholesterol, the upper limit reference range gradually dropped to the point where it is now 200 (mg/dL).
The same situation occurred with homocysteine reference ranges. Up until recently, it was considered normal to have a homocysteine blood reading as high as 15 (mm/L). Most reference ranges now provide a chart showing that homocysteine levels above 7 increase risk of heart attack and stroke.
Its not just blood laboratory reference ranges that fail to provide physicians and patients with optimal numbers. For example, when your blood pressure is checked, a diastolic number up to 90 (mm Hg) is considered normal. Yet a diastolic blood pressure reading over 85 is associated with an increased stroke risk. A high percentage of people over age 60 have diastolic readings over 85 and this is the age group most vulnerable to stroke. So when your doctor checks your blood pressure and says its normal, your response should be that normal is not good enough, since it is also normal for people over age 60 to suffer a stroke. Instead, you should ask your doctor what is the optimal range. In the case of diastolic blood pressure, taking steps to keep it at 85 or below could greatly reduce long-term vascular damage. It is important to note that mid-life hypertension predisposes people to stroke later in life, so keeping blood pressure readings in optimal ranges is important at any age.
Scientists are now examining thyroid hormone reference ranges and their findings indicate that it may be time to change the way laboratories report TSH results.
The Thyroid Stimulating Hormone (TSH) Test
The standard blood test used to determine thyroid gland hormone output is the thyroid stimulating hormone test (TSH). When there is a deficiency in thyroid hormone, the pituitary gland releases more TSH to signal the thyroid gland to produce more hormones.
When the TSH test is in normal range, doctors usually assume that the thyroid is secreting enough thyroid hormone. The question raised by The Lancet authors, however, is whether todays reference range for TSH reflects optimal thyroid hormone status.
The TSH reference range used by many laboratories is between 0.2 to 5.5 (mU/L). A greater TSH number is indicative of a thyroid hormone deficiency. That is because the pituitary is over-producing TSH based on lack of thyroid hormones in the blood. Any reading over 5.5 alerts a doctor to a thyroid gland problem and that thyroid hormone therapy may be warranted.
The trouble is that the TSH reference range is so broad that most doctors will interpret a TSH reading as low as 0.2 to be as normal as a 5.5 reading. The difference between 0.2 and 5.5, however, is an astounding 27-fold. It would seem almost absurd to think that a person could be in an optimal state of thyroid health anywhere along this 27-fold parameter, i.e. TSH readings between 0.2 and 5.5.
A review of published findings about TSH levels reveals that readings over 2.0 may be indicative of adverse health problems relating to insufficient thyroid hormone output. One study showed that individuals with TSH values over 2.0 have an increased risk of developing overt hypothyroid disease over the next 20 years.15 Other studies show that TSH values over 1.9 indicate abnormal pathologies of the thyroid, specifically autoimmune attacks on the thyroid gland itself that can result in significant impairment.
More ominous is a study showing that TSH values over 4.0 increase the prevalence of heart disease, after correction of other known risk factors. Another study showed that administration of thyroid hormone lowered cholesterol in patients with TSH ranges of 2.0 to 4.0, but had no effect in lowering cholesterol in patients whose TSH range was between 0.2 and 1.9. This study indicates that in people with elevated cholesterol, TSH values over 1.9 could indicate that a thyroid deficiency is the culprit causing excess production of cholesterol, whereas TSH levels below 2.0 would indicate no deficiency in thyroid hormone status.
Doctors routinely prescribe cholesterol-lowering drugs to patients without properly evaluating their thyroid status. Based on the evidence presented to date, it might make sense for doctors to first attempt to correct a thyroid deficiency (based on a TSH value over 1.9) instead of first resorting to cholesterol-lowering drugs.
In a study to evaluate psychological well being, impairment was found in patients with thyroid abnormalities who were none-the-less within normal TSH reference ranges.
Defying the reference ranges
The authors of The Lancet study stated that, the emerging epidemiological data begin to suggest that TSH concentrations above 2.0 (mU/L) may be associated with adverse effects.
The authors prepared a chart based on previously published studies that provide guidance when interpreting the results from TSH blood tests. Here are three highlights from their chart that may be useful in determining what your TSH values really mean:
[TD]TSH greater than 2.0
[TD]Increased 20-year risk of hypothyroidism and increased risk of thyroid autoimmunity[/TD]
[TD]TSH greater than 4.0 [/TD]
[TD] Greater risk of heart disease[/TD]
[TD]TSH between 2.0 and 4.0 [/TD]
[TD]Cholesterol levels decline in response to thyroxine (T4) therapy[/TD]
Despite presenting these intriguing findings, The Lancet authors stated that more studies are needed to define optimal TSH level as between 0.2 and 2.0 instead of between 0.2 and 5.5. As a health conscious person, however, this type of precise information provides an opportunity to correct a medical condition that has been unresponsive to mainstream therapies, or possibly prevent disorders from developing in the first place.
This means if you suffer from depression, heart disease, high cholesterol, chronic fatigue, poor mental performance or any of the many other symptoms associated with thyroid deficiency, you may want to ask your doctor to defy the reference ranges and try thyroid replacement therapies.
Measuring thyroid hormone levels
TSH is just one blood test that doctors use to assess thyroid status. Other blood tests measure the actual amount of thyroid hormone found in the blood.
The primary hormone secreted by the thyroid gland is called thyroxine (T4). The T4 is then converted in the peripheral tissues into metabolically active triiodothyronine (T3).
Doctors often test for TSH and T4 together, but this may not accurately reflect thyroid deficiency in tissues throughout the body. One study found that psychological well being could be improved if T3 (like the drug Cytomel) is added to T4 (like the drug Synthroid) therapy, while maintaining thyroid function broadly within the standard reference ranges.[19,20] What this means is that even when TSH and T4 blood tests are within normal ranges, a person can still be deficient in peripheral T3 and benefit from Cytomel therapy.
Since T3 is the metabolically active form of thyroid hormone, some doctors use it exclusively in lieu of T4 drugs like Synthroid. The FDAs recent notice to ban synthetic T4 drugs like Synthroid because of inconsistent potencies helps to validate the following statement made by Dr. Broda Barnes more than 50 years ago:
While the FDA has found many problems with T4 drugs, the T3 drug Cytomel has produced consistent clinical results and is not a subject of the FDAs proposed ban. Dr. Barnes fought the drug companies over synthetic T4 drugs for years and recommended desiccated thyroid (Armour) as the therapy of choice for most patients.
An article in the New England Journal of Medicine described a study in which patients with hypothyroidism showed greater improvements in mood and brain function if they received treatment with Armour thyroid rather than Synthroid (thyroxine). The authors also detected biochemical evidence that thyroid hormone action was greater after treatment with Armour thyroid.
It would appear that Dr. Broda Barnes has been vindicated.
All hormone reference ranges may be antiquated
Its not just thyroid hormone deficiency that goes unrecognized by so many physicians. Conventional medicine has neglected virtually all the hormone imbalances that develop as a part of growing older. The result is that aging people suffer a variety of discomforts and lethal diseases that are correctable and preventable if simple hormone adjustments are made.
[TD] Standard versus Optimal[/TD]
[TD] A persons risk of contracting lethal disease, suffering debilitating disorders and prematurely aging can be partially predicted based on the findings of blood tests that assess hormone levels. What follows are the Standard Reference Ranges compared to the Optimal Ranges for a 60-year old male:[/TD]
[TD]280-500 ug/dL [/TD]
[TD]Under 5 uU/mL[/TD]
[TD]Under 2.1 mU/L[/TD]
Aging men, for instance, often suffer from excess production of insulin and estrogen, with simultaneous deficiencies of free testosterone and DHEA. If a physician were to test blood levels of all four of these hormones, the standard reference ranges are so wide that most men would fall into the so-called normal category.
Standard reference ranges indicate that dangerously high insulin and estrogen levels are normal in elderly men. So are heart attacks, stroke, cancer, benign prostate enlargement, weight gain, Type II diabetes, kidney impairment and a host of other diseases that are associated with excess insulin and estrogen.
For instance, the standard reference ranges for free testosterone and DHEA show that very low levels are perfectly normal for aging men. Its no coincidence that these same aging men (with low testosterone/DHEA) suffer high rates of depression, memory loss, atherosclerosis, senility, impotency, high cholesterol, abdominal obesity, fatigue and a host of other diseases related to low blood levels of testosterone and DHEA.[22-34]
When it comes to assessing hormone status, standard reference ranges have failed aging humans in a terrible way. The reason is that reference ranges are adjusted to reflect a persons age. Since it is normal for an aging person to have imbalances of critical hormones, standard laboratory reference ranges are not flagging dangerously high levels of estrogen and insulin or deficient levels of testosterone, thyroid and DHEA. The box Standard versus Optimal on this page shows standard hormone blood reference ranges for men and compares them to what the optimal ranges should be.
Most doctors still believe that imbalances of life-sustaining hormones are normal for aging people. These physicians think that nothing should be done to restore hormone profiles to youthful ranges (and almost never test hormone levels anyway).
The problem is that aging people no longer accept that they should contract the diseases that happen to fit into their age category. In other words, more 65-year olds are demanding the health and vitality enjoyed by a younger person. This is not possible if 65-year olds allow their hormone levels to stagnate in todays archaic reference ranges. If you are 80 years old and are told that your hormone profile is normal for your age, tell your doctor that you would prefer the hormone profile of a 25-year old since you perceive a 25-year old as having more vitality and a reduced risk of contracting lethal diseases than an 80-year old.
Optimizing your hormone levels
The Life Extension Foundation has published extensive protocols relating to optimal male and female hormone modulation. If you log on to www.lef.org , you can access the following updated hormone-related protocols:
If you are a Foundation member and dont have access to a computer, call 1-800-544-4440 and we will print out and mail these protocols to you at no charge.
Aging people who adjust their hormone profiles to fit a more youthful profile can turn back some of the effects that time has inflicted on their bodies. In order to accomplish this, however, you must defy the standard laboratory reference ranges and seek the blood values of a much younger person.
If your doctor wont prescribe these critical blood hormone tests, or if the retail cost is prohibitive, call 1-800-208-3444 to find out how you can obtain these tests by mail order at prices below those charged by commercial laboratories.
For longer life,
1. Pop VJ, Maartens LH, Leusink G, van Son MJ, Knottnerus AA, Ward AM, Metcalfe R, Weetman AP. Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab 1998 Sep;83(9):3194-7.
2. Michalopoulou G, Alevizaki M, Piperingos G, Mitsibounas D, Mantzos E, Adamopoulos P, Koutras DA. High serum cholesterol levels in persons with high-normal TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 1998 Feb;138(2):141-5.
3. Hagen K, Bjoro T, Zwart JA, Vatten L, Stovner LJ, Bovim G. Low headache prevalence amongst women with high TSH values. Eur J Neurol 2001 Nov;8(6):693-9.
4. Spierings EL. Daily migraine with visual aura associated with an occipital arteriovenous malformation. Headache 2001 Feb;41(2):193-7.
5. Saito I, Saruta T. Hypertension in thyroid disorders. Endocrinol Metab Clin North Am 1994 Jun;23(2):379-86.
6. Stanosz S. [Levels of thyroid hormones and thyrotropic hormone in serum of women with perimenopausal arterial hypertension] Ginekol Pol 1992;63(3):130-3.
7. Krassas GE. Thyroid disease and female reproduction. Fertil Steril 2000 Dec;74(6):1063-70.
8. Lincoln SR, Ke RW, Kutteh WH. Screening for hypothyroidism in infertile women. J Reprod Med 1999 May;44(5):455-7.
9. Vierhapper H. [Assessment of thyroid gland function in unwanted infertility==indications for TRH test and clinical impact from the viewpoint of the endocrinologist] Acta Med Austriaca 1997;24(4):133-5.
10. Colin M Dayan, Ponnusamy Saravanan, Graham Bayly Whose normal thyroid function is betteryours or mine? Commentary The Lancet 2002 Aug 03; 360 (9330): 353.
11. ADVANCEDATA, from Vital & Health Statistics of The National Center for Health Statistics, US Department of Health and Education Welfare, No. 5, February 22, 1977, Public Health Service Health Resources Administration. A Comparison of Levels of Serum Cholesterol of Adults 18-74 Years of Age in the Untied States in 1960-62 and 1971-74.
12. Mahanonda N, Leowattana W, Kangkagate C, Lolekha P, Pokum S.Homocysteine and restenosis after percutaneous coronary intervention. J Med Assoc Thai 2001 Dec;84 Suppl 3:S636-44.
13. Robinson K, Mayer EL, Miller DP, Green R, van Lente F, Gupta A, Kottke-Marchant K, Savon SR, Selhub J, Nissen SE, et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 1995 Nov 15;92(10):2825-30.
14. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998 Jun 13;351(9118):1755-62.
15. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995 Jul;43(1):55-68.
16. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000 Feb 15;132(4):270-8.
17. Michalopoulou G, Alevizaki M, Piperingos G, et al. High serum cholesterol levels in persons with high-normal TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 1998; 138: 141-45.
18. Pollock MA, Sturrock A, Marshall K, Davidson KM, Kelly CJ, McMahon AD, McLaren EH. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. BMJ 2001 Oct 20;323(7318):891-5.
19. Walsh JP, Stuckey BG. What is the optimal treatment for hypothyroidism? Med J Aust 2001 Feb 5;174(3):141-3.
20. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999 Feb 11;340(6):424-9.
21. Toft AD. Thyroid hormone replacementone hormone or two? N Engl J Med 1999 Feb 11;340(6):469-70.
22. Seidman SN, Walsh BT Testosterone and depression in aging men. Am J Geriatr Psychiatry 1999 Winter;7(1):18-33.
23. Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 1999 Feb;84(2):573-7.
24. Schweiger U, Deuschle M, Weber B, Korner A, Lammers CH, Schmider J, Gotthardt U, Heuser I Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med 1999 May-Jun;61(3):292-6.
25. Rabkin JG; Wagner GJ; Rabkin R Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. J Clin Psychopharmacol Feb 1999, 19 (1) p19-27.
26. Tan RS, Pu SJ. The andropause and memory loss: is there a link between androgen decline and dementia in the aging male? Asian J Androl 2001 Sep;3(3):169-74.
27. Janowsky JS, Chavez B, Orwoll E. Sex steroids modify working memory. J Cogn Neurosci 2000 May;12(3):407-14.
28. Phillips GB, Pinkernell BH, Jing TY The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 1994 May;14(5):701-6.
29. The Testosterone Syndrome, Eugene Shippen and Fryer, W., p. 116.
30. Maximize Your Vitality & Potency, Jonathan Wright and Lenard, L., pp. 146-47.
31. Super T, Karlis Ullis, M.D., Shackman, J., and Ptacek, G., pp. 43-44.
32. Gelfand MM, Wiita B. Androgen and estrogen-androgen hormone replacement therapy: a review of the safety literature, 1941 to 1996. Clin Ther 1997 May-Jun;19(3):383-404; discussion 367-8.
33. Gooren LJ Endocrine aspects of ageing in the male. Mol Cell Endocrinol 1998 Oct 25;145(1-2):153-9.
34. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992 Oct;75(4):1092-8.
Retrieved On : 14 January 2014
[SIZE=5]From : LE Magazine November 2002 http://www.lef.org/magazine/mag2002/nov2002_awsi_01.html [/SIZE]